2022 showed Xi Jinping is not invincible; 2023 will be "rocky year" for him

2022 Showed Xi Jinping Is Not Invincible; 2023 Will Be “Rocky Year” for Him | GZERO World

What a year 2022 has been for Xi Jinping.

On the one hand, China's leader made clear he's the big boss after the 20th Communist Party Congress. On the other, he's been forced to roll back his zero-COVID policy following protests and the damage to the economy.

What will 2023 hold for Xi?

“It will be a rocky year for China,” former US State Department official Anne-Marie Slaughter tells Ian Bremmer on GZERO World. Moving away from lockdowns was long overdue, but the big problem now is that a large part of the elderly population is unvaccinated.

And it's very striking, she adds, that Xi had to reverse course when he realized he couldn't stop the protests.

For international relations expert Tom Nichols, the experience humbled Xi, whose "regime has been cut down to size." China, he points out, is no longer 10 feet tall like in the early days of COVID but just another government facing the same problems they all did during the pandemic.

Watch the GZERO World episode: On Russia’s reckoning, China’s vulnerability & US democracy’s Dunkirk

More from GZERO Media

U.S. President Donald Trump speaks with Democratic Republic of the Congo's Foreign Minister Therese Kayikwamba Wagner and Rwanda's Foreign Minister Olivier Nduhungirehe on June 27, 2025.
REUTERS

On June 27, the Democratic Republic of Congo and Rwanda signed a US-mediated peace accord in Washington, D.C., to end decades of violence in the DRC’s resource-rich Great Lakes region. The agreement commits both nations to cease hostilities, withdraw troops, and to end support for armed groups operating in eastern Congowithin 90 days.

What if the next virus isn’t natural, but deliberately engineered and used as a weapon? As geopolitical tensions rise and biological threats become more complex, health security and life sciences are emerging as critical pillars of national defense. In the premiere episode of “The Ripple Effect: Investing in Life Sciences”, leading experts explore the dual-use nature of biotechnology and the urgent need for international oversight, genetic attribution standards, and robust viral surveillance.

A woman lights a cigarette placed in a placard depicting Hungary's Prime Minister Viktor Orbán, during a demonstration, after the Hungarian parliament passed a law that bans LGBTQ+ communities from holding the annual Pride march and allows a broader constraint on freedom of assembly, in Budapest, Hungary, on March 25, 2025.
REUTERS/Marton Monus

Hungary’s capital will proceed with Saturday’s Pride parade celebrating the LGBTQ+ community, despite the rightwing national government’s recent ban on the event.